DNMT3A and acute myeloid leukemia: In addition, more than half of the mutations occurred at amino acid R882,52 which were later confirmed to be dominant‐negative, leading to decreased catalytic activity of DNMT3A and focal hypomethylation, whereas wild‐type DNMT3A R882 showed a hypermethylation pattern in AML DNA.53, 54